UPDATE: BTIG Downgrades Nektar Therapeutics (NKTR) to Neutral
Tweet Send to a Friend
(Updated - March 15, 2022 6:37 AM EDT)
BTIG analyst Robert Hazlett downgraded Nektar Therapeutics (NASDAQ: NKTR) from Buy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
BTIG analyst Robert Hazlett downgraded Nektar Therapeutics (NASDAQ: NKTR) from Buy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
